m-RNA Synthesis Service Market Report 2026

m-RNA Synthesis Service Market Overview

• m-RNA Synthesis Service market size has reached to $4.99 billion in 2025 • Expected to grow to $7.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.6% • Growth Driver: Rising Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomic Sequencing And Demand For Tailored Therapies • Market Trend: Primrose Bio Advances mRNA Synthesis With Launch Of Prima RNApols Enzyme • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under m-RNA Synthesis Service Market?

A messenger ribonucleic acid (mRNA) synthesis service refers to the process of producing custom messenger RNA molecules through in vitro transcription based on a provided deoxyribonucleic acid (DNA) template. These services are used for applications such as vaccine development, gene therapy, and research in protein expression and functional genomics. The main types of mRNA synthesis services are mRNA vaccine synthesis and mRNA drug synthesis. mRNA vaccine synthesis is the laboratory process of producing messenger RNA sequences that instruct cells to make a specific protein, triggering an immune response to protect against infectious diseases. These services are used in application areas including vaccine development, therapeutic development, research and development, and diagnostics, and are utilized by end-user industries, including pharmaceutical companies, biotechnology firms, academic and research institutions, and contract research organizations (CROs).

What Is The m-RNA Synthesis Service Market Growth Forecast?

The m-rna synthesis service market size is expected to see strong growth in the next few years. It will grow to $7.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing pipeline of mrna-based therapeutics, rising demand for personalized medicine solutions, expansion of gene therapy research, growing reliance on outsourcing synthesis services, increasing regulatory approvals for mrna products. Major trends in the forecast period include increasing demand for custom mrna constructs, rising adoption of gmp-grade mrna production, growing use of scalable in vitro transcription platforms, expansion of rapid turnaround synthesis services, enhanced focus on high-purity mrna outputs.

Global m-RNA Synthesis Service Market Segmentation

1) By Type: mRNA Vaccine Synthesis, mRNA Drug Synthesis 2) By Application Area: Vaccine Development, Therapeutic Development, Research and Development, Diagnostics 3) By End-user Industry: Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutions, Contract Research Organizations (CROs) Subsegments: 1) By mRNA Vaccine Synthesis: Infectious Disease Vaccines, Cancer Vaccines, Personalized Vaccines 2) By mRNA Drug Synthesis: Protein Replacement Therapies, Gene Editing Therapeutics, Cell Therapy Support

What Is The Driver Of The m-RNA Synthesis Service Market?

The increasing focus on personalized medicine is expected to propel the growth of the mRNA synthesis service market going forward. Personalized medicine refers to a medical approach that tailors treatment and healthcare decisions to an individual’s genetic makeup, lifestyle, and environment. Personalized medicine is increasing due to advancements in genomic sequencing, which allow for more precise identification of individual genetic variations linked to disease and treatment response. mRNA synthesis services help increase the focus on personalized medicine by enabling the rapid and precise production of mRNA-based therapies tailored to an individual’s genetic makeup, allowing for more effective and targeted treatments. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, a significant increase from 6 in 2022. Among these, seven were cancer drugs, and three were designed for other diseases and conditions. Therefore, the increasing focus on personalized medicine is driving the growth of the mRNA synthesis service market.

Key Players In The Global m-RNA Synthesis Service Market

Major companies operating in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, APExBIO Technology LLC

Global m-RNA Synthesis Service Market Trends and Insights

Major companies operating in the mRNA synthesis service market are focusing on developing innovative solutions, such as RNA polymerase innovations, to improve the efficiency, yield, and safety of mRNA synthesis. RNA polymerase innovations refer to the development of advanced enzymes that enhance the transcription process, minimize side effects such as double-stranded RNA formation, and increase the overall quality of mRNA for vaccines and therapeutics. For instance, in March 2025, Primrose Bio Inc., a US-based biotechnology company, launched Prima RNApols to enhance the efficiency and scalability of mRNA synthesis. This enzyme features enhanced processivity and high-fidelity transcription, enabling it to produce longer and more stable mRNA strands with reduced error rates. Its robust performance in in vitro transcription systems minimizes impurities and boosts overall yield, offering a reliable and scalable solution for companies engaged in mRNA-based drug development. This innovation is particularly valuable in the growing field of personalized medicine, where precise and efficient mRNA synthesis is essential.

What Are Latest Mergers And Acquisitions In The m-RNA Synthesis Service Market?

In December 2024, Novo Holdings A/S, a Denmark-based investment firm, acquired Catalent Inc. for $16.5 billion. With this acquisition, Novo Holdings aims to strengthen its position in the life sciences sector by enhancing its capabilities in drug development and supply while fostering sustainable value creation through an engaged ownership model. Catalent Inc. is a US-based company that specializes in mRNA synthesis services for therapeutics and vaccines.

Regional Outlook

North America was the largest region in the m-RNA synthesis service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the m-RNA Synthesis Service Market?

The mRNA synthesis service market consists of revenues earned by entities by providing services such as template DNA preparation, codon optimization, stability and storage testing, and regulatory support for clinical applications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the m-RNA Synthesis Service Market Report 2026?

The m-rna synthesis service market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the m-rna synthesis service industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.